JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2024  1,200
2023  1,500
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 60(2026) N 1 p. 49-70; DOI 10.1134/S0026893325700566 Full Text

O.A. Zemlianaia1, V.V. Strelnikov1*, D.V. Zaletaev1

Pathology of Methylation, Demethylation, and Methylated DNA Binding Machinery

1Bochkov Medical Genetics Research Center, Moscow, 115522 Russia

*vstrel@list.ru
Received - 2025-07-25; Revised - 2025-08-18; Accepted - 2025-08-18

Along with genetic factors, epigenetic factors have been convincingly demonstrated to determine the development of pathological processes to date. These include hereditary and nonhereditary changes in expression of a specific gene without any corresponding structural changes in its nucleotide sequence. Epigenetic mechanisms regulating gene expression include cytosine methylation in CpG dinucleotides, post- translational modification of histones, ATP-dependent chromatin remodeling, and inactivation of gene expression by various types of noncoding RNAs. At the same time, pathological variants of genes involved in epigenetic mechanisms can lead to both Mendelian syndromes and multi-symptom complexes, in which the main manifestations are mental retardation, delayed physical development, neurological symptoms, and mild signs of dysgenesis. New pathological conditions due to variants in epigenetic machinery genes have been described in the modern literature, and previously described syndromic conditions have been combined into certain "continuous sequences of clinical features" in some cases. The review focuses on germline disorders of genes involved in methylation, demethylation, and methylated DNA binding machinery and their phenotypic manifestations. Somatic variants, which often lead to oncological diseases, are beyond the scope of this review.

epigenetic regulation, gene expression, DNA methylation/demethylation, DNA methyltransferases, methylated DNA-binding proteins, Mendelian syndromes



JMB-FOOTER RAS-JOURNALS